429 related articles for article (PubMed ID: 32732010)
21. The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
Roffi M; Guagliumi G; Ibanez B
Circulation; 2020 Jun; 141(24):1951-1953. PubMed ID: 32315205
[No Abstract] [Full Text] [Related]
22. COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.
Khalid N; Chen Y; Case BC; Shlofmitz E; Wermers JP; Rogers T; Ben-Dor I; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):946-949. PubMed ID: 32423791
[TBL] [Abstract][Full Text] [Related]
23. Impact of COVID-19 on reperfusion strategies for acute coronary syndromes.
Torres-Escobar G; González-Pacheco H; Cruz JLB; Arias-Mendoza A; Araiza-Garaygordobil D
Arch Cardiol Mex; 2020; 90(Supl):62-66. PubMed ID: 32523136
[TBL] [Abstract][Full Text] [Related]
24. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience.
Rodríguez-Leor O; Cid-Álvarez B; Pérez de Prado A; Rossello X; Ojeda S; Serrador A; López-Palop R; Martín-Moreiras J; Rumoroso JR; Cequier Á; Ibáñez B; Cruz-González I; Romaguera R; Moreno R; ; Villa M; Ruíz-Salmerón R; Molano F; Sánchez C; Muñoz-García E; Íñigo L; Herrador J; Gómez-Menchero A; Gómez-Menchero A; Caballero J; Ojeda S; Cárdenas M; Gheorghe L; Oneto J; Morales F; Valencia F; Ruíz JR; Diarte JA; Avanzas P; Rondán J; Peral V; Pernasetti LV; Hernández J; Bosa F; Lorenzo PLM; Jiménez F; Hernández JMT; Jiménez-Mazuecos J; Lozano F; Moreu J; Novo E; Robles J; Moreiras JM; Fernández-Vázquez F; Amat-Santos IJ; Gómez-Hospital JA; García-Picart J; Blanco BGD; Regueiro A; Carrillo-Suárez X; Tizón H; Mohandes M; Casanova J; Agudelo-Montañez V; Muñoz JF; Franco J; Del Castillo R; Salinas P; Elizaga J; Sarnago F; Jiménez-Valero S; Rivero F; Oteo JF; Alegría-Barrero E; Sánchez-Recalde Á; Ruíz V; Pinar E; Pinar E; Planas A; Ledesma BL; Berenguer A; Fernández-Cisnal A; Aguar P; Pomar F; Jerez M; Torres F; García R; Frutos A; Nodar JMR; García K; Sáez R; Torres A; Tellería M; Sadaba M; Mínguez JRL; Merchán JCR; Portales J; Trillo R; Aldama G; Fernández S; Santás M; Pérez MPP
Rev Esp Cardiol (Engl Ed); 2020 Dec; 73(12):994-1002. PubMed ID: 32917566
[TBL] [Abstract][Full Text] [Related]
25.
Dehghani P; Davidson LJ; Grines CL; Nayak K; Saw J; Kaul P; Bagai A; Garberich R; Schmidt C; Ly HQ; Giri J; Meraj P; Shah B; Garcia S; Sharkey S; Wood DA; Welt FG; Mahmud E; Henry TD
Am Heart J; 2020 Sep; 227():11-18. PubMed ID: 32425198
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 30-day mortality and myocardial scar indices for patients treated with prehospital reduced dose fibrinolytic followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction.
Solhpour A; Chang KW; Arain SA; Balan P; Zhao Y; Loghin C; McCarthy JJ; Vernon Anderson H; Smalling RW
Catheter Cardiovasc Interv; 2016 Nov; 88(5):709-715. PubMed ID: 27028120
[TBL] [Abstract][Full Text] [Related]
27. The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.
Peiyuan H; Jingang Y; Haiyan X; Xiaojin G; Ying X; Yuan W; Wei L; Yang W; Xinran T; Ruohua Y; Chen J; Lei S; Xuan Z; Rui F; Yunqing Y; Qiuting D; Hui S; Xinxin Y; Runlin G; Yuejin Y;
PLoS One; 2016; 11(11):e0165672. PubMed ID: 27812152
[TBL] [Abstract][Full Text] [Related]
28. Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic.
Wang N; Zhang M; Su H; Huang Z; Lin Y; Zhang M
J Int Med Res; 2020 Oct; 48(10):300060520966151. PubMed ID: 33108941
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.
Mafham MM; Spata E; Goldacre R; Gair D; Curnow P; Bray M; Hollings S; Roebuck C; Gale CP; Mamas MA; Deanfield JE; de Belder MA; Luescher TF; Denwood T; Landray MJ; Emberson JR; Collins R; Morris EJA; Casadei B; Baigent C
Lancet; 2020 Aug; 396(10248):381-389. PubMed ID: 32679111
[TBL] [Abstract][Full Text] [Related]
30. Urgent Percutaneous Coronary Artery Intervention and Coronary Artery Bypass Grafting in STEMI Patients with Confirmed COVID-19.
Keskin G; Uysal A; Erturk E; Hafız E; Dogan OF
Heart Surg Forum; 2021 Jun; 24(3):E564-E574. PubMed ID: 34173766
[TBL] [Abstract][Full Text] [Related]
31. Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study.
Shavadia J; Welsh R; Gershlick A; Zheng Y; Huber K; Halvorsen S; Steg PG; Van de Werf F; Armstrong PW
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 28525886
[TBL] [Abstract][Full Text] [Related]
32. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
Kirtane AJ; Bangalore S
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
[No Abstract] [Full Text] [Related]
33. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
Li YH; Huang WC; Hwang JJ;
Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
[No Abstract] [Full Text] [Related]
34. Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction.
Tomasoni D; Adamo M; Italia L; Branca L; Chizzola G; Fiorina C; Lupi L; Inciardi RM; Cani DS; Lombardi CM; Curello S; Metra M
J Cardiovasc Med (Hagerstown); 2020 Nov; 21(11):874-881. PubMed ID: 32941325
[TBL] [Abstract][Full Text] [Related]
35. In-Hospital Management and Outcomes of Acute Myocardial Infarction Before and During the Coronavirus Disease 2019 Pandemic.
Huang B; Xu C; Liu H; Deng W; Yang Z; Wan J; Yan H; Cao G; Chen J; Jiang H
J Cardiovasc Pharmacol; 2020 Nov; 76(5):540-548. PubMed ID: 33170591
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study).
Welsh RC; Van de Werf F; Westerhout CM; Goldstein P; Gershlick AH; Wilcox RG; Danays T; Bluhmki E; Lopes RD; Steg PG; Armstrong PW
Am J Cardiol; 2014 Sep; 114(6):811-9. PubMed ID: 25108302
[TBL] [Abstract][Full Text] [Related]
37. Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network).
Siontis KC; Barsness GW; Lennon RJ; Holmen JL; Wright RS; Bell MR; Gersh BJ
Am J Cardiol; 2016 Jun; 117(12):1904-10. PubMed ID: 27131614
[TBL] [Abstract][Full Text] [Related]
38. Multiple spontaneous coronary thrombosis causing ST-elevation myocardial infarction in a patient with COVID-19.
Kurdi H; Obaid DR; UlHaq Z; Ionescu A; Sekar B
Br J Hosp Med (Lond); 2020 Jul; 81(7):1-6. PubMed ID: 32730159
[No Abstract] [Full Text] [Related]
39. Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).
Mahmud E; Dauerman HL; Welt FGP; Messenger JC; Rao SV; Grines C; Mattu A; Kirtane AJ; Jauhar R; Meraj P; Rokos IC; Rumsfeld JS; Henry TD
J Am Coll Cardiol; 2020 Sep; 76(11):1375-1384. PubMed ID: 32330544
[TBL] [Abstract][Full Text] [Related]
40. Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.
Butala NM; Patel NK; Chhatwal J; Vahdat V; Pomerantsev EV; Albaghdadi M; Sakhuja R; Rosenzweig A; Elmariah S
Circ Cardiovasc Interv; 2020 Nov; 13(11):e010027. PubMed ID: 33167699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
